FAWLAW represents plaintiffs and defendants in patent litigation in a wide variety of technology sectors, including semiconductors, medical devices, telecommunications, social networking, and many others.  We appear in federal district courts across the United States, the International Trade Commission, the Patent Trial and Appeal Board, and the United States Court of Appeals for the Federal Circuit.  One of our partners is registered to practice before the Patent and Trademark Office.  Another of our lawyers worked for a defensive patent aggregator in the development of market and litigation intelligence.  

We assist individual inventors and large and small patent owners in the enforcement and monetization of their patents.  Our work is focused on litigation, but we make evaluation of potential licensing strategies a part of each engagement.

Patent infringement lawsuits filed in district court now typically lead to petitions for inter partes review by the Patent Trial and Appeal Board.  We have successfully opposed petitions for inter partes review filed by patent litigation defendants and their proxies, and we defend our clients’ patents before the Board when inter partes review is instituted.

Our work for defendants in patent cases is concentrated on the representation of early stage technology companies.  We offer an alternative to the often excessive cost of patent litigation, with our flexible approach to billing, low overhead, and focus on cost-effective litigation strategies.

Our lawyers bring both technical know-how and superior advocacy skills to our cases.  Our litigation teams come from varied educational and practice backgrounds that enable us to offer a comprehensive solution to the issues presented in patent litigation.  

FAWLAW lawyers are also active in the development of patent law and policy.  We regularly speak on developments in patent law and the role of patents in protecting intellectual property, and we monitor the Supreme Court and Federal Circuit dockets for opportunities to provide amicus curiae support on issues of significance to the patent system.